ubenimex has been researched along with Recrudescence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamatani, S; Imai, T; Isobe, K; Itoh, S; Kuromi, T; Nanba, M; Nomi, K; Okada, H | 1 |
| Hiraoka, A; Masaoka, T; Shibata, H | 1 |
1 trial(s) available for ubenimex and Recrudescence
| Article | Year |
|---|---|
Immunopotentiation with Ubenimex for prevention of leukemia relapse after allogeneic BMT. The Study Group of Ubenimex for BMT.
Topics: Adjuvants, Immunologic; Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Female; Graft vs Host Disease; Graft vs Host Reaction; Humans; Infant; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Recurrence | 1992 |
1 other study(ies) available for ubenimex and Recrudescence
| Article | Year |
|---|---|
Induction of graft-versus-host disease and a graft-versus-leukemia effect using ubenimex in a patient with infantile leukemia relapsing after an unrelated cord blood transplant.
Topics: Cord Blood Stem Cell Transplantation; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Infant; Leucine; Leukemia; Male; Recurrence; Remission Induction; Transplantation, Homologous | 2002 |